Vascular Closure Device Market Size

Vascular Closure Device Market Size

Vascular Closure Device Market size was valued at USD 1.7 billion in 2023 and is expected to exhibit growth at a CAGR of 6.3% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in medical technology, increasing prevalence of cardiovascular diseases, rising demand for minimally invasive procedures, and expanding healthcare expenditure, among other contributing factors.

Moreover, the global rise in the prevalence of cardiovascular diseases, such as coronary artery disease, peripheral interventions disease, and stroke, has led to an increase in diagnostic and therapeutic catheterization procedures. For instance, according to the British Heart Foundation, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. VCDs are essential in managing the access sites used in these procedures, as they help achieve hemostasis quickly and efficiently. The growing number of cardiovascular interventions directly fuels the demand for vascular closure devices.
 

Furthermore, rising healthcare expenditure, particularly in developing regions, has led to the modernization of healthcare infrastructure and increased access to advanced medical technologies. Improved healthcare facilities and increased investment in cardiovascular care drive the adoption of vascular closure devices, contributing to market growth.
 

Vascular closure device is a medical device used to achieve hemostasis at the access site following a vascular procedure, such as angiography or angioplasty. It facilitates the sealing of the puncture site in an artery, typically the femoral or radial artery, to prevent bleeding and promote quicker patient recovery. VCDs offer an alternative to manual compression methods, improving patient comfort and reducing complications.